Parsimony has unfortunately become an enduring test of the institution's legitimacy

As we end 2025, the latest outcome reveals the profound and worsening flaws in our institutional HTA framework. We need to consider the enduring implications of denying patients access to funded innovation, how those denials serve the institution's interests, and whether we are willing to accept the harms they entail. …